{"disease":{"id":"leukodystrophy","name":"leukodystrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05368038","title":"ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Albert Einstein College of Medicine","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT03639285","title":"Natural History, Diagnosis, and Outcomes for Leukodystrophies","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT04090268","title":"Precision Exercise in Children With Malignant Hemopathies","phase":"NA","overall_status":"UNKNOWN","enrollment_count":380,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT05939232","title":"Registry of X-linked Adrenoleukodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04675749","title":"Quality of Life in Women with X-linked Adrenoleukodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Leipzig University Medical Center","has_results":false},{"nct_id":"NCT02171104","title":"MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":149,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT06224413","title":"A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":false},{"nct_id":"NCT03231878","title":"A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Minoryx Therapeutics, S.L.","has_results":false},{"nct_id":"NCT03278899","title":"A Study to Prospectively Assess Disease Progression in Male Children With X-ALD","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"NeuroVia, Inc.","has_results":false},{"nct_id":"NCT04781010","title":"Characterization and Outcome of Children With Leukodystrophy: An Observational Study at Sohag University Hospital","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT00889174","title":"The Nosology and Etiology of Leukodystrophies of Unknown Causes","phase":"","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT04687007","title":"SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Leipzig University Medical Center","has_results":false},{"nct_id":"NCT03771898","title":"A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT03852498","title":"A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":true},{"nct_id":"NCT01896102","title":"A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":true},{"nct_id":"NCT05443906","title":"Home Exercise for Individuals with Neurodegenerative Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","has_results":false},{"nct_id":"NCT03727555","title":"IT and IV Lentiviral Gene Therapy for X-ALD","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT05003648","title":"Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01887938","title":"An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT01510028","title":"Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT04973657","title":"A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Viking Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02595489","title":"A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT04628364","title":"The Natural History of Metachromatic Leukodystrophy Study (HOME Study)","phase":"","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"National Organization for Rare Disorders","has_results":false},{"nct_id":"NCT01560182","title":"Gene Therapy for Metachromatic Leukodystrophy (MLD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Orchard Therapeutics","has_results":false},{"nct_id":"NCT00418561","title":"Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT04528706","title":"A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":13,"lead_sponsor_name":"Minoryx Therapeutics, S.L.","has_results":false},{"nct_id":"NCT00633139","title":"Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT00681811","title":"Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT07046338","title":"Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT06030648","title":"MT2022-01: MSCs for ALD","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":10,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT03725670","title":"Direct Lentiviral Injection Gene Therapy for MLD","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT03392987","title":"A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Orchard Therapeutics","has_results":false},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT04283227","title":"OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"Orchard Therapeutics","has_results":false},{"nct_id":"NCT04303416","title":"Plasma Exchange With Albumin in AMN Patients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Pujol, Aurora, M.D.","has_results":false},{"nct_id":"NCT03367546","title":"Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT02723448","title":"Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT01963650","title":"Natural History Study of Children With Metachromatic Leukodystrophy","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT01093105","title":"An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT00639132","title":"The Natural History of Metachromatic Leukodystrophy","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT05755568","title":"A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03639844","title":"BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Bellicum Pharmaceuticals","has_results":false},{"nct_id":"NCT02021266","title":"Single Patient Expanded Access Protocol: Metabolic Boost","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Talaris Therapeutics Inc.","has_results":false},{"nct_id":"NCT02233257","title":"Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT02084121","title":"Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Talaris Therapeutics Inc.","has_results":false}],"total":49},"guidelines":[],"source":"Drug Landscape verified database"}